Cargando…
Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer
BACKGROUND: SEMA3B is known as an inhibitor of angiogenesis and cell proliferation. During carcinogenesis, the loss of SEMA3B function is observed, which results in the progression of neoplastic changes. The aim of this study was to evaluate the expression profile of SEMA3B in endometrial cancer (G1...
Autores principales: | Dziobek, Konrad, Opławski, Marcin, Grabarek, Beniamin, Zmarzły, Nikola, Januszyk, Piotr, Adwent, Iwona, Dąbruś, Dariusz, Leśniak, Ewa, Kiełbasiński, Robert, Kieszkowski, Przemysław, Boroń, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598462/ https://www.ncbi.nlm.nih.gov/pubmed/31217417 http://dx.doi.org/10.12659/MSM.916762 |
Ejemplares similares
-
Changes in Expression Pattern of SEMA3F Depending on Endometrial Cancer Grade - Pilot Study
por: Dziobek, Konrad, et al.
Publicado: (2019) -
Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer
por: Oplawski, Marcin, et al.
Publicado: (2019) -
Differences in the Expression Pattern of mRNA Protein SEMA3F in
Endometrial Cancer in vitro under Cisplatin Treatment
por: Kieszkowski, Przemysław, et al.
Publicado: (2020) -
Expression of NRP-1 and NRP-2 in Endometrial Cancer
por: Oplawski, Marcin, et al.
Publicado: (2019) -
Assessment of Expression of Homeobox A5 in Endometrial Cancer on the mRNA and Protein Level
por: Dziobek, Konrad, et al.
Publicado: (2020)